| 000 | 01636 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513132832.0 | ||
| 264 | 0 | _c19980213 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0008-6363 | ||
| 024 | 7 |
_a10.1016/s0008-6363(97)00160-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarr, C S | |
| 245 | 0 | 0 |
_aEvidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia. _h[electronic resource] |
| 260 |
_bCardiovascular research _cOct 1997 |
||
| 300 |
_a52-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDinucleoside Phosphates _xpharmacology |
| 650 | 0 | 4 |
_aHeart Atria _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xmetabolism |
| 650 | 0 | 4 | _aMyocardial Reperfusion |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Agonists |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Antagonists |
| 650 | 0 | 4 | _aReceptor, Adenosine A3 |
| 650 | 0 | 4 |
_aReceptors, Purinergic P1 _xphysiology |
| 650 | 0 | 4 |
_aXanthines _xpharmacology |
| 700 | 1 | _aHill, R J | |
| 700 | 1 | _aMasamune, H | |
| 700 | 1 | _aKennedy, S P | |
| 700 | 1 | _aKnight, D R | |
| 700 | 1 | _aTracey, W R | |
| 700 | 1 | _aYellon, D M | |
| 773 | 0 |
_tCardiovascular research _gvol. 36 _gno. 1 _gp. 52-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0008-6363(97)00160-0 _zAvailable from publisher's website |
| 999 |
_c9384850 _d9384850 |
||